| Date | Subject |
|---|
19/6/2020
10:49 | cjohn: It's also a satisfactory resolution of the serious governance issues following the disgraceful loan, with the relevant offenders moved out swiftly.
And repayment of the loan guaranteed by the Sandhus putting UEX stock into escrow.
The negative note is that the company are going to cover the Sandhu's £134k legal costs with respect to their employment by the group and the loan issue.
|
19/6/2020
08:38 | otemple3: https://www.charltonillingworth.co.uk/rec-uex/"Valuation -Shareholders can expect a 17% 37% return over 7-15 months on the basis of these assumptions. The original deal with Honeycomb was expected to provide 72p/share to shareholders, an extra 6p-16p/share.Conclusion -Looks like a decent run off return for shareholders from the current price, and a sad end for the company"
|
06/5/2020
13:16 | cjohn: "The lack of corporate governance and the disgraceful action by directors awarding themselves a loan is well highlighted in todays TIMES."
Let's hope it's a lesson they take to heart.
There's been clear value here post the falling through of the Honeycomb deal, but the corporate governance is going to make any potential shareholder pause. Only one independent director raised the alarm. What were the others doing? What was the Chairman doing?
"The sooner UEX sells its portfolio and self liquidates the better."
Hear, hear to that.
|
06/5/2020
10:30 | stuffee: SL, I agree The Times has delivered a well deserved kick. I do hope there are no more unsavoury transactions between the 2% shareholders and the company, I fear where there's smoke there may be...
As others have mentioned our dear friend ST really knows how to pick them. I think he likes selecting small companies on very low ratings without researching the reason investors have failed to deliver a decent rating. I've suffered from some of his recommendations - the classic being Constellation Healthcare, which was bought in by management, at what appeared to be a discounted price, and subsequently proved to be a complete fraud. To really cheer up former shareholders, the Liquidator is now proceeding to recover all the bid proceeds from the former shareholders, which is possible under US legislation; I've ignored the various writs and demands.
The sooner UEX sells its portfolio and self liquidates the better.
|
05/5/2020
13:42 | stemis: I suppose on the flip side, it's less than 1% of assets, with little impact on results, there's no personal gain by the CEO, it's simply a badly executed charitable 'donation' (wrt the interest foregone) and there's an implication that the board were aware.
Clearly these guys haven't come to terms with UEX being a plc and not a private company and the level of governance is inadequate. The days of UEX being a listed company seem numbered.
I do kind of feel there is value to be had here (although I don't hold) as a wind up opportunity. Unaudited tNAV at 31.12.19 was 83.9p a share and the company pretty much broke even in 2019. It may make a loss in 2020 if they wind down the balance sheet without commensurate cost savings but gross costs in 2019 were only 5.5p a share so it shouldn't be material impact. There's a possibly of loan write downs but the difference between 83.9p and 40p gives a lot of headway...
|
05/5/2020
10:13 | cjohn: https://www.investegate.co.uk/urban-exposure-plc--uex-/eqs/update-on-strategic-review-and-related-party-transaction-with-urban-exposure-philanthropy-limited/20200505070058EOQHX/
Oh dear. This is not good news.
What the hell were the CEO and his wife thinking about!!?
Let's hope they get on with re-paying this loan ASAP.
|
24/4/2020
18:04 | stuffee: I admire your enthusiasm posters but I'm pretty doubtful anything will materialise.
Has W, itself made any announcement and if so, could someone please direct us to it. Approaching shareholders rather than the Board in current circumstances all looks pretty amateurish to me and is NOT the way to agree any transaction. Did W receive the required consent to approach shareholders without any announcement and if not a pending mega knuckle wrap due. Does W have any recognised advisor? If so, why have they let the share price rip away by 50% without a proper announcement? Oh and does W have the dough? Settling the acquisition in zero coupon irredeemable bonds would not appeal to me.
I've been in UEX since virtually the start and I fear it's not the stock anyone should hold in current markets. I'd certainly grab 73 or whatever with both hands but I doubt I will ever see it.
Would welcome any further info from other posters and maybe I've missed something.
|
07/4/2020
09:01 | stemis: UEX planning to sue for damages.
|
06/4/2020
16:33 | stemis: Stemis - it's development loans to housebuilders, isn't it?
Presumably based on assumption that interest and principal will be paid.
In general yes, but how much cash do they have, any debt, who have they lent to, what security etc...
At 31.12.19 the NAV was 82.7p.
At 18.2.20 the par value of their loan portfolio, inc KKR JV, was £116.5m, which is 73.5p. According to the circular, the buyer (HHL)
"...may terminate the agreement if between exchange and completion of the Lendco SPA there is or is likely to be a material adverse change in the financial condition of Lendco (defined for these purposes as a reduction in the net asset value of Lendco as at 18 February 2020 in excess of £10 million) which results from a breach or default by a borrower under any of the loans in Lendco’s loan portfolio, or if there is a material breach of the Lendco SPA.
UEX are presumably trying to claim that there hasn't !!
Not sure what else there is, although they committed to providing £7.1m (4.5p) of working capital to the MBO of the management arm.
Since the sale price of the two was £115.4m (72.8p) and they expected to distribute 73p, there must be enough cash apart from that to settle all the costs of sale/wind up etc.
|
06/4/2020
14:04 | cjohn: I can't help thinking that UEX is looking like a bargain at these levels.
|
PLUS1
